Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Krystal Biotech Inc
About KRYS
Krystal Biotech, Inc. is an integrated, commercial-stage biotechnology company. The Company is focused on the discovery, development, and commercialization of genetic medicines to treat diseases with high unmet medical needs. Its product candidates in various stages of clinical and preclinical development include KB407, KB408, KB707, KB105, KB801, KB803, KB304 and KB301. Its commercial product, VYJUVEK, is a redosable gene therapy, and a genetic medicine approved in the United States and Europe for the treatment of dystrophic epidermolysis bullosa. KB407 is being developed for the treatment of Cystic Fibrosis. KB408 is being developed for the treatment of Alpha-1 Antitrypsin Deficiency, a rare lung disease. KB707 is being developed for the treatment of solid tumors. KB105 is being developed for TGM1-Deficient Autosomal Recessive Congenital Ichthyosis. KB803 is a redosable eye drop formulation of B-VEC, designed for the treatment of ocular complications.
Find out what a historical investment in Krystal Biotech Inc would be worth today using our KRYS stock calculator.
Market Capitalisation
$8.65B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
197.15K
High today
$303.37
Low today
$296.13
Open price
$297.09
52-week high
$319.48
52-week low
$122.80
Ready to start your investing journey with Stake?
Open an accountHow do I buy KRYS shares in Australia?
Buying KRYS shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Krystal Biotech Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in KRYS
What is the ticker symbol of Krystal Biotech Inc?
The ticker symbol for Krystal Biotech Inc is KRYS.
How much is one share of KRYS?
One share of KRYS is valued at $301.24 as of 20 May 2026.
What is the market capitalisation of Krystal Biotech Inc KRYS?
As of 20 May 2026 Krystal Biotech Inc has a market cap of $8.65B.
What is the P/E ratio of KRYS?
The Price to Earnings ratio of KRYS is 39.22.
What is the Earnings Per Share of KRYS?
The Earnings Per Share of KRYS is $7.48.
What is the 52-week high for Krystal Biotech Inc stock?
The Krystal Biotech Inc 52-week high stock price is $319.48.
What is the 52-week low for Krystal Biotech Inc stock?
The Krystal Biotech Inc 52-week low stock price is $122.80.
Can I buy KRYS shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy KRYS shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in KRYS on Stake
- Buy KRYS from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of KRYS from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
KRYS related stocks